NASDAQ: CABA
Cabaletta Bio Inc Stock Ownership - Who owns Cabaletta Bio?

Insider buying vs selling

Have Cabaletta Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CABA insiders and whales buy or sell their stock.

CABA Shareholders

What type of owners hold Cabaletta Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bain Capital Life Sciences Investors LLC19.07%9,677,125$14.52MInstitution
Adage Capital Partners GP LLC17.40%8,829,758$13.24MInstitution
T Rowe Price Investment Management Inc13.39%6,793,788$10.19MInstitution
Jennison Associates LLC11.86%6,020,167$9.03MInstitution
Cormorant Asset Management LP9.85%5,000,000$7.50MInstitution
Alyeska Investment Group LP9.46%4,800,000$7.20MInstitution
Vanguard Group Inc6.80%3,450,727$5.18MInstitution
Heights Capital Management Inc6.20%3,144,106$4.72MInstitution
Price T Rowe Associates Inc4.31%2,187,039$3.28MInstitution
Jefferies Financial Group Inc3.94%1,997,208$3.00MInstitution

1 of 3

CABA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CABA94.52%5.48%
CNTX76.49%1.46%Net BuyingNet Buying
STRO65.79%18.24%Net SellingNet Selling
ARTV54.13%45.87%Net SellingNet Selling
PMVP55.62%44.38%Net SellingNet Selling

Cabaletta Bio Stock Ownership FAQ

Who owns Cabaletta Bio?

Cabaletta Bio (NASDAQ: CABA) is owned by 143.42% institutional shareholders, 8.32% Cabaletta Bio insiders, and 0.00% retail investors. James E. Flynn is the largest individual Cabaletta Bio shareholder, owning 1.63M shares representing 3.21% of the company. James E. Flynn's Cabaletta Bio shares are currently valued at $2.44M.

If you're new to stock investing, here's how to buy Cabaletta Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.